Russian Pharmaceutical Companies Export Potential in Emerging Regional Clusters

Elena Sapir (), Igor Karachev and Mingzhu Zhang
Additional contact information
Elena Sapir: Demidov Yaroslavl State University
Igor Karachev: Demidov Yaroslavl State University
Mingzhu Zhang: LLC СРD Arkhangelsk thermal power

Economy of region, 2016, vol. 1, issue 4, 1194 - 1204

Abstract: This article analyzes a diverse range of the enterprise’s export potential growth factors in emerging pharmaceutical clusters of Central European Russia. Classification and comparative analysis were used to identify export potential attributes (production, finance, labor and marketing), which have allowed to reveal the strong connection of cluster and regional factor groups with the results of export performance. The purpose of the study is to provide exports-seeking pharmaceutical companies with a set of tools to enhance their export potential. The hypothesis that the cumulative impact of the specified attributes leads to the strengthening of pharmaceutical cluster export potential and promotes an effective integration of the region in the world economic space, is developed and tested. The methodology combines the geo-economy-based theory with the theory of clusters competitive advantages. The impacts of export potential growth factors are estimated by using an econometric model based on math statistics. Thus, five Russian regional pharmaceutical clusters (Belgorod, Kaluga, Moscow, Oryol, Yaroslavl) are shown. Findings identify an objective causal link between enterprise export potential growth and competitiveness factors of cluster origin (network business chains, production functions interconnectedness and flexibility, production localization). An action plan for the purpose of the maximum use of competitive advantages of the cluster organization for export activities of the entities of the pharmaceutical industry is developed. Conclusions and recommendations of the study are intended to enterprises in pharmaceutical industry and regions’ public authorities, implementing cluster development strategies. It is thus essential to improve marketing and organizational innovations, reduction of commercial expenses under the cluster environment, development of drugs production and delivery chains from R&D to end-users in order to enjoy greater economic benefits from Russian pharmaceutical firms’ export potential growth.

Keywords: regional cluster; export potential of the enterprise; geo-economics; micro-level and meso-level factors; pharmaceutical industry (search for similar items in EconPapers)
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://economyofregion.ru/Data/Issues/ER2016/Decem ... er2016_1194_1204.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ura:ecregj:v:1:y:2016:i:4:p:1194-1204

Access Statistics for this article

More articles in Economy of region from Centre for Economic Security, Institute of Economics of Ural Branch of Russian Academy of Sciences
Bibliographic data for series maintained by Alexey Naydenov ().